EUVIMEDEUVIMED entdecken
Crossref

Indole‐based aryl sulfides target the cell wall of Staphylococcus aureus without detectable resistance

Aditya G Lavekar iD, Ritesh Thakare iD, Saima iD, Danish Equbal iD, Sidharth Chopra iD, Arun K Sinha iD

Drug Development Research · 2024

DOI: 10.1002/ddr.22123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Development Research, 2024. Verfasst von Aditya G Lavekar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medicinal and Process Chemistry, CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh, India. Hauptthemen laut MEDLINE: Staphylococcus aureus, Methicillin-Resistant Staphylococcus aureus. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: CSIR, UGC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sulfur‐containing classes of the scaffold “Arylthioindoles” have been evaluated for antibacterial activity; they demonstrated excellent potency against methicillin‐resistant Staphylococcus aureus (MRSA) as well as against vancomycin‐resistant strains and a panel of clinical isolates of resistant strains. In this study, we have elucidated the mechanism of action of lead compounds, wherein they target the cell wall of S. aureus . Further, S. aureus failed to develop resistance against two lead compounds tested in a serial passage experiment in the presence of the compounds over a period of 40 days. Both the compounds demonstrated comparable in vivo efficacy with vancomycin in a neutropenic mice thigh infection model. The results of these antibacterial activities emphasize the excellent potential of thioethers for developing novel antibiotics and may fill in as a target for the adjustment of accessible molecules to develop new powerful antibacterial agents with fewer side effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Staphylococcus aureusMethicillin-Resistant Staphylococcus aureusAnimalsMiceVancomycinSulfidesAnti-Bacterial AgentsCell WallIndolesMicrobial Sensitivity Tests

Stichwörter der Autor:innen

antibioticsarylthioindolesmethicillin-resistant Staphylococcus aureusstructure-activity relationship

Substanzen

VancomycinSulfidesAnti-Bacterial AgentsIndoles

Autor:innen und Institutionen

  • Division of Medicinal and Process Chemistry, CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh, India.
  • Academy of Scientific and Innovative Research (AcSIR), New Delhi, India.
  • Division of Molecular Microbiology and Immunology, CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh, India.
  • Department of Cell and Cancer Biology, UMass Chan Medical School, Worcester, Massachusetts, USA.
  • School of Advanced Chemical Sciences, Solan, Himachal Pradesh, India.
  • Ranchi University, Ranchi, Jharkhand, India.

ORCID-Profile: Aditya G Lavekar, Ritesh Thakare, Saima, Danish Equbal, Sidharth Chopra, Arun K Sinha

Förderung

  • CSIR
  • UGC

Zitieren

APA

Lavekar, A. G., Thakare, R., Saima, Equbal, D., Chopra, S., & Sinha, A. K. (2024). Indole‐based aryl sulfides target the cell wall of Staphylococcus aureus without detectable resistance. Drug Development Research. https://doi.org/10.1002/ddr.22123

Vancouver

Lavekar AG, Thakare R, Saima, Equbal D, Chopra S, Sinha AK. Indole‐based aryl sulfides target the cell wall of Staphylococcus aureus without detectable resistance. Drug Development Research. 2024. doi:10.1002/ddr.22123

BibTeX
@article{Lavekar2024,
  author = {Lavekar, Aditya G and Thakare, Ritesh and Saima and Equbal, Danish and Chopra, Sidharth and Sinha, Arun K},
  title = {Indole‐based aryl sulfides target the cell wall of Staphylococcus aureus without detectable resistance},
  journal = {Drug Development Research},
  year = {2024},
  doi = {10.1002/ddr.22123}
}
Kostenlos starten →